In Treatment of Duchenne muscular dystrophy(DMD) Duchenne muscular dystrophy (DMD) is a type of muscular dystrophy, characterized by muscle weakness and atrophy due to the effect of the body’s immune system mechanisms. Defahit 6mg Syrup slows the progression of DMD. The exact mechanism by which it acts is unclear, but it is thought to help mediate the condition by suppressing the immune system. For DMD, Defahit 6mg Syrup is approved to be used in children above 5 years of age. In Treatment of Inflammatory conditions Defahit 6mg Syrup gives relief in inflammatory conditions that affect muscles and joints such as arthritis and ankylosing spondylitis. It also helps manage other inflammatory conditions such as asthma, inflammatory bowel disease, uveitis, ulcerative colitis, and allergies. It works by blocking certain chemicals that cause pain and swelling. In Treatment of Autoimmune conditions Defahit 6mg Syrup gives relief in autoimmune conditions like psoriasis, rheumatoid arthritis, eczema, atopic dermatitis, etc. It works by lowering your immune system’s response to these conditions thereby reducing symptoms such as swelling, pain, itching, and other allergic-type reactions. In Treatment of Cancer Defahit 6mg Syrup helps in the treatment of a variety of cancers, such as leukemia, lymphoma, and multiple myeloma. It works by suppressing the immune system thereby reducing inflammation around the site of cancer. It is used specifically to decrease swelling (edema), associated with tumors of the spine and brain. Moreover, it helps to treat or prevent allergic reactions in cancer patients.
Defahit 6mg Syrup is safe to use in patients with kidney disease. No dose adjustment of Defahit 6mg Syrup is recommended. Dose alterations may be required in severe kidney disease. Discuss with your child’s doctor thoroughly before giving Defahit 6mg Syrup to your child.
Defahit 6mg Syrup should be used with caution in patients with liver disease. Dose adjustment of Defahit 6mg Syrup may be needed. Please consult your doctor.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: SAG Health Science Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Biotic Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zuventus Healthcare Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vindcare Lifesciences || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Venistro Biotech || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Agex Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Stallion Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Agrim Pharmaceuticals || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Vexilla Healthcare || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Amon Biotech || ₹14.5/tablet (25% cheaper)